Charter Communications, Inc. (LON:0HW4)

Sage Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	27,294	38,933	45,137	43,671	86,327	96,849
Market Cap Growth	20.97%	-13.74%	3.36%	-49.41%	-10.86%	23.11%
Enterprise Value	102,664	118,448	124,560	126,918	155,664	160,222
Last Close Price	200.43	273.19	306.07	280.26	484.38	484.42
PE Ratio	7.10	9.59	12.62	10.41	25.12	41.04
PS Ratio	0.68	0.89	1.05	0.97	2.26	2.75
PB Ratio	1.84	2.47	3.91	4.19	6.44	4.37
P/FCF Ratio	-	15.42	17.33	9.48	13.59	18.50
P/OCF Ratio	-	3.38	3.98	3.53	7.20	9.08
EV/Sales Ratio	2.46	2.69	2.91	2.83	4.08	4.55
EV/EBITDA Ratio	6.03	6.77	7.56	7.15	10.28	12.09
EV/EBIT Ratio	10.35	11.22	12.91	12.24	18.89	26.05
EV/FCF Ratio	32.69	46.91	47.82	27.56	24.50	30.61
Debt / Equity Ratio	4.73	4.93	6.77	7.89	5.12	2.78
Debt / EBITDA Ratio	4.20	4.29	4.59	4.48	4.39	4.49
Debt / FCF Ratio	22.38	30.74	30.02	17.84	10.81	11.78
Asset Turnover	0.37	0.37	0.37	0.38	0.36	0.33
Quick Ratio	0.28	0.26	0.28	0.30	0.26	0.36
Current Ratio	0.33	0.31	0.31	0.33	0.29	0.40
Return on Equity (ROE)	32.65%	34.00%	38.59%	38.10%	21.97%	10.64%
Return on Assets (ROA)	5.62%	5.56%	5.27%	5.44%	4.87%	3.59%
Return on Capital (ROIC)	7.31%	7.15%	6.80%	7.02%	6.18%	4.49%
Return on Capital Employed (ROCE)	9.90%	9.70%	9.20%	9.40%	8.60%	6.30%
Earnings Yield	14.08%	10.43%	7.93%	9.61%	3.98%	2.44%
FCF Yield	11.51%	6.49%	5.77%	10.55%	7.36%	5.41%
Buyback Yield / Dilution	2.99%	4.35%	7.58%	14.82%	7.76%	6.49%

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.